DOJ Alleges Kickbacks in Medicare Advantage Broker Commissions
The DOJ files a lawsuit accusing insurers and brokerages of illicit kickbacks in Medicare Advantage plan enrollments, raising compliance and regulatory concerns.
Colorado Home Insurance Rates Surge Amid Rising Wildfire Risks
Colorado faces significant home insurance premium increases due to wildfire risks and extreme weather, prompting new regulations to stabilize the market and support homeowners.
Litigation Funding Raises Premiums, Alters Liability Insurance Market Dynamics
Third-party litigation funding drives higher premium costs and reduced liability insurance availability, impacting underwriting and claims trends in commercial auto, umbrella, and product liability lines.
IAG to Acquire RAC WA Insurance Business, Adding $1.5B to GWP
Insurance Australia Group (IAG) will acquire the RAC WA insurance business for $1.35 billion, boosting its gross written premium by $1.5 billion. The deal, pending ACCC approval, includes a 20-year exclusive distribution and brand licensing agreement.
Optum Develops AI-Based Risk Coding for Medicare Patients Amid DOJ Scrutiny
Optum is creating AI-driven risk coding to improve Medicare patient assessments, coinciding with DOJ investigations into Medicare Advantage practices by UnitedHealth Group.
Manslaughter Sentencing in Assisted Suicide Case with Life Insurance Implications
Mark Switzer sentenced for manslaughter in 2017 assisted suicide impacting life insurance and raising legal, compliance issues under Colorado's Medical Aid In Dying law.
California Fire Victims Face Insurance Challenges Amid State Farm Rate Hike
California fire victims face ongoing challenges with State Farm insurance claims as the state approves a 17% emergency homeowners rate hike amid scrutiny of insurer practices and regulatory responses.
Insurer Denials and Administrative Burdens Highlight U.S. Health Insurance Time Tax
Extensive insurer claim denials and administrative hurdles impose a substantial time tax on U.S. healthcare consumers, affecting productivity and trust in health systems. Employer accountability and regulatory gaps remain critical issues.
CMS Narrows Medicare Drug Price Negotiation Timeline for Hyluronidase-Enhanced Biologics
CMS accelerates Medicare price negotiations for drugs with hyaluronidase, impacting biologic drug pricing and pharmaceutical companies like Halozyme Therapeutics and Johnson & Johnson.
CMS Finalizes 2026 Updates for Medicare Advantage and Part D Programs
CMS issued final rules and updates for Medicare Advantage and Part D programs for 2026, including Inflation Reduction Act implementations and inpatient care protections.